Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-003274)

Filing Details

Accession Number:: 0001181431-13-003274
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-01-15 17:48:05
Reporting Period:: 2013-01-09

Filing Date:: 2013-01-15
Accepted Time:: 2013-01-15 17:48:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
911326	Synageva Biopharma Corp	GEVA	Biological Products, (No Disgnostic Substances) (2836)	561808663

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1081916	J Thomas Tisch	667 Madison Ave. New York NY 10065		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-01-09	21,039	$47.53	373,560	No	4	P	Indirect	Through trusts

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Through trusts

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	378,435	Direct